Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment
aslo known as AFQ056
AUY-922 (500 nM) in combination with NSC 118218 more effectively induces apoptosis in cells in co-culture than either drug alone
2-a]pyrazin-3(7H)-one
and the IC(50) value of the compound against CaM-KII is approximately 10 microg/ml
PF-3845 RB597 Avasimibe encapsulated in human serumPF 3845 is a fatty acid amide hydrolase (FAAH) inhibitor, and acts in the nervous system to reverse LPS induced tactile allodynia in mice. PF 3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Treatment with PF3845 inactivated FAAH activity and enhanced the AEA levels in the brain. It reduced neurodegeneration in the dentate gyrus, and up regulated the expression of Bcl 2 and
US$ 149.97
US$ 13.95
US$ 59.95
US$ 19.95
US$ 60.00
US$ 190.00
US$ 80.00
US$ 106.00
US$ 59.95
US$ 29.95